| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.4B | $1.3B | $1.1B | $1.0B | $1.1B | $0.3B | $0.3B | $0.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $-0.0B | $0.0B | $0.1B | $-0.1B | $0.0B | $0.0B |
| EPS (Basic) | $4.64 | $2.45 | — | — | — | $-4.50 | $0.59 | $1.11 |
| EPS (Diluted) | $4.48 | $2.39 | — | — | — | $-4.50 | $0.58 | $1.08 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.8B | $3.5B | $3.1B | $2.9B | $3.0B | $3.1B | $3.0B | $2.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Total Liabilities | $2.9B | $2.7B | $2.4B | $2.1B | $2.1B | $2.2B | $2.1B | $1.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.9B | $0.8B | $0.7B | $0.7B | $0.9B | $0.8B | $0.9B | $0.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.3B | $0.2B | $-0.0B | $0.0B | $0.0B | $0.1B | $0.1B |
| Investing Cash Flow | $-0.3B | $-0.3B | $-0.1B | $-0.0B | $0.0B | $-0.1B | $0.0B | $-0.0B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.0B | $0.1B | $-0.0B | $-0.0B | $-0.0B | $0.0B | $-0.0B | $-0.1B |